Telehealth Tracking as PHI Disclosure Chain: FTC HHS Enforcement Signals and Case Proof
When telehealth pages embed trackers, “engagement analytics” can become impermissible PHI disclosure. Here is the evidence chain investigators can document.
Articles
Articles
536 articles
When telehealth pages embed trackers, “engagement analytics” can become impermissible PHI disclosure. Here is the evidence chain investigators can document.
Credits are being traded like proof, but the chain of custody for claims is brittle. Here is how integrity breaks across data, accounting, and retirement.
A practitioner playbook for local-first AI: NPU inference, privacy-by-design, model routing governance, and drift testing between local and cloud answers.
Export licensing is becoming a supply-chain audit standard. The next policy step is to make evidence portable, reduce friction, and protect against diversion risk.
Physical infrastructure projects increasingly rely on AI decisions. That changes what “proof” must look like: investigators should demand traceable evidence packaging, not checklists.
The EDPB’s harmonised DPIA template pushes digital health teams to convert sensor and AI data flows into repeatable risk controls and validation evidence, not one-off paperwork.
NRC Part 53 can shorten timelines, but for advanced reactors the schedule hinges on how you stage evidence, digitize documentation, and manage security and review gates.
FDA’s digital health evidence push changes how trials should plan sensors, govern data, validate AI-enabled software, and control change so “digital endpoints” don’t break submissions.
Use regulatory-planning discipline to engineer Digital Product Passport data contracts, governance, and audit trails that survive the July 2026 central registry moment.
The latest intelligence on emerging risks, delivered weekly.